GABAPENTIN
- Product NDC
- 61919-660
- 11-digit product format
- 619190660
- Labeler code
- 61919
- Product ID
- 61919-660_ea4ea5a1-3104-d5dd-e053-2995a90ab48c
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- GABAPENTIN
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Direct_Rx
- Application
- ANDA090705
- Marketing category
- ANDA
- Marketing start
- 2019-08-08
- Marketing end
- 0000-00-00
- Substance
- GABAPENTIN
- Active strength
- 400 mg/1
- Pharmacologic classes
- Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61919-660-30 | 61919066030 | 30 CAPSULE in 1 BOTTLE (61919-660-30) | 30 capsule | 2019-08-08 | 0000-00-00 | No | No | Current |
| 61919-660-72 | 61919066072 | 120 CAPSULE in 1 BOTTLE (61919-660-72) | 120 capsule | 2019-08-08 | 0000-00-00 | No | No | Current |
| 61919-660-90 | 61919066090 | 90 CAPSULE in 1 BOTTLE (61919-660-90) | 90 capsule | 2018-09-25 | 0000-00-00 | No | No | Current |